3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
95
Breast Neoplasms
12
Neoplasms
7
Leiomyoma
4
Rare Diseases
2
Polycystic Ovary Syndrome
2
Neoplasm Metastasis
2
Adenocarcinoma
2
Uveal Melanoma
1
Uterine Neoplasms
1
Urogenital Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Skin Neoplasms
1
Skin Diseases
1
Sexual Dysfunction, Physiological
1
Respiratory Tract Diseases
1
Prostatic Diseases
1
Primary Dysautonomias
1
Premenopausal Breast Cancer
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Patient Compliance
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Neoplasms, Glandular and Epithelial
1
Myofibroma
1
Myelodysplastic Syndromes
1
Melanoma
1
Lymphatic Metastasis
1
Lower Urinary Tract Symptoms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Interventions
relacorilant
4
Hydrochlorothiazide
4
Nutrition Assessment
3
Labetalol
2
Bevacizumab
2
Angiotensin-Converting Enzyme Inhibitors
2
Amlodipine
2
ziprasidone
1
sacubitril and valsartan sodium hydrate drug combination
1
pembrolizumab
1
fimasartan
1
enzalutamide
1
clevidipine
1
cediranib
1
bicalutamide
1
aliskiren
1
Zolpidem
1
Warfarin
1
Vitamin D
1
Vecuronium Bromide
1
Vancomycin
1
Tumor Necrosis Factors
1
Tranexamic Acid
1
Tobramycin
1
Thiazides
1
Therapeutics
1
Surveys and Questionnaires
1
Sunitinib
1
Sulindac
1
Spironolactone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hypertension
×
Leuprolide
×
Clear all
NCT05700903
2026-03-02
ARCH
University of Colorado, Denver
Phase 4
Completed
10 enrolled